REFERENCES
- Seibel I, Cordini D, Rehak M et al. Local recurrence after primary proton beam therapy in uveal melanoma: risk factors, retreatment approaches, and outcome. Am J Ophthalmol 2015; 160: 628–636.
- Aalto Y, Eriksson L, Seregard S et al. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci 2001; 42: 313–317.
- White VA, Chambers JD, Courtright PD et al. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer 1998; 83: 354–359.
- Damato B, Dopierala J, Klaasen A et al. Multiplex ligation‐dependent probe amplification of uveal melanoma: correlation with metastatic death. Invest Ophthalmol Vis Sci 2009; 50: 3048–3055.
- Krishna Y, Kalirai H, Thornton S et al. Genetic findings in treatment‐naive and proton‐beam‐radiated iris melanomas. Br J Ophthalmol 2016; 100: 1012–1016.
- Ehlers JP, Worley L, Onken MD et al. Integrative genomic analysis of aneuploidy in uveal melanoma. Clin Cancer Res 2008; 14: 115–122.
- Gold AS, Murray TG, Markoe AM et al. Uveal melanoma gene expression status post radiotherapy. Optom Vis Sci 2014; 91: e14–e17.